The impact of wight-loss drugs to our business 'is negligable', says Medtronic CEO
Geoff Martha, Medtronic CEO, joins 'Closing Bell Overtime' to talk quarterly results, the impact of weight-loss drugs, and more.
Medtronic (MDT) Q2 Earnings Beat Estimates, 2024 View Up
Medtronic (MDT) Q2 results reflect broad strength across businesses and geographies, benefiting from durable fundamentals.
Medtronic delivers beat and raise for 2Q sending shares higher
Medtronic PLC (NYSE:MDT) shares moved higher in early trade on Tuesday as the medical devices company raised its fiscal 2024 sales and profit guidance. For the full year ending in April 2024, it ex...
Medtronic's second-quarter earnings top estimates as medical device maker raises guidance
Medtronic PLC's stock MDT rose 0.8% premarket Tuesday, after the medical device maker posted better-than-expected earnings for its fiscal second quarter and raised guidance. Dublin-based Medtronic ...
Medical device maker Medtronic raises fiscal 2024 profit view
Medtronic on Tuesday raised its annual profit forecast for the second time this year, banking on higher demand for its medical devices as surgery volumes pick up pace.
Medtronic's (MDT) Symplicity Spyral RDN System Gets FDA Boost
Medtronic (MDT) receives the FDA approval for Symplicity blood pressure procedure for the treatment of hypertension.
US FDA approves Medtronic's blood pressure treatment device for use
The U.S. Food and Drug Administration on Friday approved the use of Medtronic's treatment device in a surgery called renal denervation in patients whose high blood pressure cannot be controlled by ...
Why Medtronic (MDT) Could Beat Earnings Estimates Again
Medtronic (MDT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Unlocking Q2 Potential of Medtronic (MDT): Exploring Wall Street Estimates for Key Metrics
Beyond analysts' top -and-bottom-line estimates for Medtronic (MDT), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the qua...
3 Long-Term Stocks You'll Regret Not Buying Soon: November 2023
Amidst the uncertainty, savvy investors recognize that market downturns potentially pave the way for future prosperity. However, the quest for long-term stocks to buy soon remains fraught with chal...
Where Will Medtronic Stock Be in 5 Years?
Medtronic's growth rate has been underwhelming in recent years. Growth is a priority now and Medtronic is selling off majority stake in slower-growing areas of its business.
Medtronic (MDT) Ascends While Market Falls: Some Facts to Note
Medtronic (MDT) closed the most recent trading day at $72.08, moving +1.98% from the previous trading session.
Medtronic (MDT) Outperforms Broader Market: What You Need to Know
Medtronic (MDT) reachead $73.42 at the closing of the latest trading day, reflecting a +1.19% change compared to its last close.
Medtronic (MDT) Laps the Stock Market: Here's Why
Medtronic (MDT) closed the most recent trading day at $70.56, moving +0.84% from the previous trading session.
Related Companies